Leukemia-associated translocation products able to activate RAS modify PML and render cells sensitive to arsenic-induced apoptosis

Oncogene

Volumn 22, Issue 44, 2003, Pages 6900-6908

  Puccetti, Elena ^a   Beissert, Tim ^a   Güller, Saskia ^a   Li, Jun E ^a   Hoelzer, Dieter ^a   Ottmann, Oliver G ^a   Ruthardt, Martin ^a,b  

^a GOETHE UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

AML; APL; Arsenic; CML; PML; RAS

Indexed keywords

ARSENIC; ARSENIC TRIOXIDE; BCR ABL PROTEIN; CELL PROTEIN; PROMYELOCYTIC LEUKEMIA PROTEIN; RAS PROTEIN; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL DEATH; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; FIBROBLAST; HUMAN; HUMAN CELL; LEUKEMIA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ANTINEOPLASTIC AGENTS; APOPTOSIS; ARSENICALS; ENZYME INHIBITORS; FIBROBLASTS; FUSION PROTEINS, BCR-ABL; GENE EXPRESSION REGULATION, LEUKEMIC; GENES, RAS; HUMANS; LEUKEMIA, LYMPHOCYTIC, ACUTE; LEUKEMIA, PROMYELOCYTIC, ACUTE; MONOCYTES; OXIDES; PHILADELPHIA CHROMOSOME; PIPERAZINES; PROTEIN ISOFORMS; PROTO-ONCOGENE PROTEINS C-ABL; PYRIMIDINES; RECEPTORS, RETINOIC ACID; TRANSGENES; TRANSLOCATION, GENETIC; TUMOR CELLS, CULTURED; U937 CELLS; UP-REGULATION;

EID: 0242574329     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1206747     Document Type: Article

References (37)

1. Bischof O, Kirsh O, Pearson M, Itahana K, Pelicci PG and Dejean A. (2002). EMBO J., 21, 3358-3369.
2. Chelbi-Alix MK, Pelicano L, Quignon F, Koken MH, Venturini L, Stadler M, Pavlovic J, Degos L and de The H. (1995). Leukemia, 9, 2027-2033.
3. Chen F, Lu Y, Zhang Z, Vallyathan V, Ding M, Castranova V and Shi X. (2001a). J. Biol. Chem., 276, 11414-11419.
4. Chen F, Zhang Z, Leonard SS and Shi X. (2001b). Oncogene, 20, 3585-3589.
5. Dyck JA, Maul GG, Miller WH, Jr, Chen JD, Kakizuka A and Evans RM. (1994). Cell, 76, 333-343.
6. El-Sabban ME, Nasr R, Dbaibo G, Hermine O, Abboushi N, Quignon F, Ameisen JC, Bex F, de The H and Bazarbachi A. (2000). Blood, 96, 2849-2855.
7. Faderl S, Talpaz M, Estrov Z, S OB, Kurzrock R and Kantarjian HM. (1999). N. Engl. J. Med., 341, 164-172.
8. Ferbeyre G, de Stanchina E, Querido E, Baptiste N, Prives C and Lowe SW. (2000). Genes Dev., 14, 2015-2027.
9. Fogal V, Gostissa M, Sandy P, Zacchi P, Sternsdorf T, Jensen K, Pandolfi PP, Will H, Schneider C and Del Sal G. (2000). EMBO J., 19, 6185-6195.
10. Forkner C and Scott T. (1931). JAMA, 97, 3-5.
11. Gianni M, Koken MH, Chelbi-Alix MK, Benoit G, Lanotte M, Chen Z and de The H. (1998). Blood, 91, 4300-4310.
12. Grignani F, Ferrucci PF, Testa U, Talamo G, Fagioli M, Alcalay M, Mencarelli A, Peschle C, Nicoletti I and Pelicci PG. (1993). Cell, 74, 423-431.
13. Jensen K, Shiels C and Freemont PS. (2001). Oncogene, 20, 7223-7233.
14. Koken MH, Daniel MT, Gianni M, Zelent A, Licht J, Buzyn A, Minard P, Degos L, Varet B and de The H. (1999). Oncogene, 18, 1113-1118.
15. Koken MH, Puvion-Dutilleul F, Guillemin MC, Viron A, Linares-Cruz G, Stuurman N, de Jong L, Szostecki C, Calvo F and Chomienne C et al. (1994). EMBO J., 13, 1073-1083.
16. Lee RK, Cai JP, Deyev V, Gill PS, Cabral L, Wood C, Agarwal RP, Xia W, Boise LH, Podack E and Harrington Jr WJ. (1999). Cancer Res., 59, 5514-5520.
17. Lissauer. (1865). Berliner klinische Wochenschrift, 2, 403-404.
18. Mahieux R, Pise-Masison C, Gessain A, Brady JN, Olivier R, Perret E, Misteli T and Nicot C. (2001). Blood, 98, 3762-3769.
19. McNeil S, Javed A, Harrington KS, Lian JB, Stein JL, van Wijnen AJ and Stein GS. (2000). J. Cell. Biochem., 79, 103-112.
20. Miller Jr WH, Schipper HM, Lee JS, Singer J and Waxman S. (2002). Cancer Res., 62, 3893-3903.
21. Muller S, Matunis MJ and Dejean A. (1998). EMBO J., 17, 61-70.
22. Pearson M, Carbone R, Sebastiani C, Cioce M, Fagioli M, Saito S, Higashimoto Y, Appella E, Minucci S, Pandolfi PP and Pelicci PG. (2000). Nature, 406, 207-210.
23. Perkins C, Kim CN, Fang G and Bhalla KN. (2000). Blood, 95, 1014-1022.
24. Puccetti E, Guller S, Orleth A, Bruggenolte N, Hoelzer D, Ottmann OG and Ruthardt M. (2000). Cancer Res., 60, 3409-3413.
25. Puccetti E, Obradovic D, Beissert T, Bianchini A, Washburn B, Chiaradonna F, Boehrer S, Hoelzer D, Ottmann OG, Pelicci PG, Nervi C and Ruthardt M. (2002). Cancer Res., 62, 7050-7058.
26. Quignon F, De Bels F, Koken M, Feunteun J, Ameisen JC and de The H. (1998). Nat. Genet., 20, 259-265.
27. Ruthardt M, Testa U, Nervi C, Ferrucci PF, Grignani F, Puccetti E, Peschle C and Pelicci PG. (1997). Mol. Cell. Biol., 17, 4859-4869.
28. Sears DA. (1988). Am. J. Med. Sci., 296, 85-86.
29. Stadler M, Chelbi-Alix MK, Koken MH, Venturini L, Lee C, Saib A, Quignon F, Pelicano L, Guillemin MC and Schindler C et al. (1995). Oncogene, 11, 2565-2573.
30. Sternsdorf T, Puccetti E, Jensen K, Hoelzer D, Will H, Ottmann OG and Ruthardt M. (1999). Mol. Cell. Biol., 19, 5170-5178.
31. Stuurman N, de Graaf A, Floore A, Josso A, Humbel B, de Jong L and van Driel R. (1992). J. Cell. Sci., 101, 773-784.
32. Valentiner W. (1865). Berliner klinische Wochenschrift, 2, 320-321.
33. Villa E, Grottola A, Buttafoco P, Colantoni A, Bagni A, Ferretti I, Cremonini C, Bertani H and Manenti F. (2001). Am. J. Gastroenterol., 96, 2973-2977.
34. Visani G, Martinelli G, Piccaluga P, Tosi P, Amabile M, Pastano R, Cavo M, Isidori A and Tura S. (2000). Leukemia, 14, 22-27.
35. Wang ZG, Ruggero D, Ronchetti S, Zhong S, Gaboli M, Rivi R and Pandolfi PP. (1998). Nat. Genet., 20, 266-272.
36. Weis K, Rambaud S, Lavau C, Jansen J, Carvalho T, Carmo-Fonseca M, Lamond A and Dejean A. (1994). Cell, 76, 345-356.
37. Zhu J, Koken MH, Quignon F, Chelbi-Alix MK, Degos L, Wang ZY, Chen Z and de The H. (1997). Proc. Natl. Acad. Sci. USA, 94, 3978-3983.